Altimmune, Inc. (NASDAQ:ALT) Q2 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Related Keywords

United States ,Scot Roberts ,Jon Wolleben ,Seamus Fernandez ,Scott Harris ,Louis Aronne ,Yasmeen Rahimi ,Patrick Trucchio ,Corinne Jenkins ,Boehringer Ingelheim Zealand ,Vipin Garg ,Stephen Harrison ,Louis Susser ,Piper Sandler ,Mayank Mamtani ,Oxford University ,Nasdaq ,Goldman Sachs ,Weill Cornell Medical School ,Pinnacle Research ,Altimmune Inc ,Call Transcript August ,Second Quarter ,Results Conference ,Rich Eisenstadt ,Chief Financial Officer ,Chief Executive Officer ,Chief Scientific Officer ,Chief Medical ,Investor Relations ,Private Securities Litigation Reform Act ,Chief Executive ,Chief Medical Officer ,Medical Director ,Roger Song ,